- Home
- STXS vs FENC Comparison
STXS vs FENC Comparison
Compare STXS & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STXS
- FENC
- Stock Information
- Founded
- STXS 1990
- FENC 1996
- Country
- STXS United States
- FENC United States
- Employees
- STXS N/A
- FENC N/A
- Industry
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STXS Health Care
- FENC Health Care
- Exchange
- STXS Nasdaq
- FENC Nasdaq
- Market Cap
- STXS N/A
- FENC 156.9M
- IPO Year
- STXS 2004
- FENC 2001
- Fundamental
- Price
- STXS $2.53
- FENC $6.57
- Analyst Decision
- STXS Strong Buy
- FENC Strong Buy
- Analyst Count
- STXS 2
- FENC 2
- Target Price
- STXS $4.50
- FENC $14.00
- AVG Volume (30 Days)
- STXS 412.8K
- FENC 58.2K
- Earning Date
- STXS 03-03-2025
- FENC 03-20-2025
- Dividend Yield
- STXS N/A
- FENC N/A
- EPS Growth
- STXS N/A
- FENC N/A
- EPS
- STXS N/A
- FENC N/A
- Revenue
- STXS $25,143,000.00
- FENC $49,348,000.00
- Revenue This Year
- STXS $3.73
- FENC $170.43
- Revenue Next Year
- STXS $54.27
- FENC $6.70
- P/E Ratio
- STXS N/A
- FENC N/A
- Revenue Growth
- STXS N/A
- FENC 278.09
- 52 Week Low
- STXS $1.66
- FENC $3.96
- 52 Week High
- STXS $3.29
- FENC $11.49
- Technical
- Relative Strength Index (RSI)
- STXS 61.33
- FENC 67.46
- Support Level
- STXS $2.26
- FENC $6.30
- Resistance Level
- STXS $2.52
- FENC $6.76
- Average True Range (ATR)
- STXS 0.13
- FENC 0.28
- MACD
- STXS 0.03
- FENC 0.06
- Stochastic Oscillator
- STXS 88.00
- FENC 93.98
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.